AIG
AVXL icon

American International Group’s Anavex Life Sciences AVXL Stock Holding History

American International Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,624
Closed -$181K – 267
2024
Q1 		$181K Sell
35,624
-305
-0.8% -$1.72K ﹤0.01% 2207
2023
Q4 		$334K Buy
35,929
+344
+1% +$2.37K ﹤0.01% 1879
2023
Q3 		$233K Buy
35,585
+1,787
+5% +$14.2K ﹤0.01% 2043
2023
Q2 		$275K Buy
33,798
+423
+1% +$3.63K ﹤0.01% 1993
2023
Q1 		$286K Buy
33,375
+664
+2% +$6.63K ﹤0.01% 1915
2022
Q4 		$303K Sell
32,711
-118
-0.4% -$1.26K ﹤0.01% 1882
2022
Q3 		$339K Buy
32,829
+889
+3% +$9.38K ﹤0.01% 1828
2022
Q2 		$320K Sell
31,940
-1,368
-4% -$13K ﹤0.01% 1872
2022
Q1 		$410K Sell
33,308
-2,344
-7% -$28.8K ﹤0.01% 1832
2021
Q4 		$618K Buy
35,652
+532
+2% +$10.1K ﹤0.01% 1685
2021
Q3 		$630K Buy
35,120
+347
+1% +$6.91K ﹤0.01% 1705
2021
Q2 		$795K Buy
34,773
+738
+2% +$10.9K ﹤0.01% 1633
2021
Q1 		$509K Buy
34,035
+3,523
+12% +$38.5K ﹤0.01% 1831
2020
Q4 		$165K Sell
30,512
-875
-3% -$4.61K ﹤0.01% 2378
2020
Q3 		$143K Buy
31,387
+101
+0.3% +$435 ﹤0.01% 2327
2020
Q2 		$154K Buy
31,286
+2,110
+7% +$7.97K ﹤0.01% 2277
2020
Q1 		$92K Buy
29,176
+2,295
+9% +$8K ﹤0.01% 2350
2019
Q4 		$70K Sell
26,881
-226
-0.8% -$593 ﹤0.01% 2781
2019
Q3 		$86K Sell
27,107
-189
-0.7% -$545 ﹤0.01% 2694
2019
Q2 		$92K Buy
+27,296
New +$84.8K ﹤0.01% 2723
2018
Q2 		– Sell
-25,210
Closed -$70K – 3081
2018
Q1 		$70K Buy
25,210
+75
+0.3% +$212 ﹤0.01% 2810
2017
Q4 		$81K Buy
25,135
+592
+2% +$2.33K ﹤0.01% 2814
2017
Q3 		$102K Buy
24,543
+1,835
+8% +$8.16K ﹤0.01% 2645
2017
Q2 		$121K Buy
22,708
+2,605
+13% +$15.1K ﹤0.01% 2604
2017
Q1 		$115K Buy
20,103
+1,329
+7% +$6.86K ﹤0.01% 2512
2016
Q4 		$74K Sell
18,774
-49
-0.3% -$175 ﹤0.01% 2748
2016
Q3 		$68.3K Buy
18,823
+28
+0.1% +$118 ﹤0.01% 2807
2016
Q2 		$115K Buy
+18,795
New +$90.8K ﹤0.01% 2521

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

American International Group's AVXL Position: Q2 2024 in Review

American International Group sold out of Anavex Life Sciences (AVXL) in Q2 2024, closing a stake of 35,624 shares — an estimated $181K sold.

American International Group first reported a position in AVXL in Q2 2016 and held it in 28 quarters. The position peaked at $795K in Q2 2021. 141 funds tracked by Wall St. Rank hold AVXL as of Q2 2024.

  • American International Group reported no remaining Anavex Life Sciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 35,624 Anavex Life Sciences shares in Q2 2024, an estimated $181K.
  • American International Group first reported a position in Anavex Life Sciences in Q2 2016 and held it in 28 quarters.
  • American International Group's Anavex Life Sciences position peaked at $795K in Q2 2021.
  • 141 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.